Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. 265: 503-509, 1990). Practice: Multiple sclerosis and viruses. Genetic studies revealed that HK2 was required for the human and mouse lung cancer cell growth in vitro and in vivo. Practice: Ion channel effects on neuron membrane … ... Korea. Identification of HK isoforms, and recognition that most tissues express only HK1 while most tumors express HK1 and HK2, stimulated reducing HK2 activity as a therapeutic option. We used 3-bromopyruvate (3-BP), a HK-II inhibitor … This site needs JavaScript to work properly. By continuing you agree to the use of cookies. BNBZ also significantly inhibits the glycolysis of SW1990 cells by targeting HK2. Practice: Effects of stroke on the brain. 2019;26(41):7285-7322. doi: 10.2174/0929867326666181213092652. 3-Bromopyruvic acid (3-BrPA), … L4900: Lonidamine mitochondrial … 15-19 … Genetic studies revealed that HK2 was required for the human and mouse lung cancer cell growth in vitro and in vivo. The study included cell viability, apoptosis, and study levels of hexokinase enzyme, pyruvate, ATP, and acidity. BNBZ significantly inhibits the glycolysis of SW1990 cells by targeting HK2. Inhibition of hypoxia-induced CA-IX enhances hexokinase II inhibitor-induced HCC apoptosis. BNBZ binds to HK2, induces apoptosis, inhibits proliferation of cancer cells. PIs can increase cell sensitivity to endoplasmic reticulum stress, leading to apoptosis of myeloma cells. "We believe we … Practice: Cancer and hexokinase. J Cheminform. eCollection 2018. Hexokinase possesses the ability to transfer an inorganic phosphate group from ATP to a substrate.  |  Antimicrobial activities. Approximately 80% of all lung cancers are non-small-cell lung cancer (NSCLC), and squamous cell carcinoma (SCC) accounts for ~20–30% of NSCLCs (3). Hexokinase (HK) activity is the first glycolytic enzymatic step; despite many attempts to inhibit HK activity, none has reached clinical application. ... Another widely studied hexokinase inhibitor is 2-deoxy-d-glucose (2-DG) that inhibits hexokinase by competing with glucose and accumulates inside the cells, which leads to inhibition of the glycolytic flux, depletion of ATP, cell-cycle … Hexokinase 2 (HK2) is one of the most highly upregulated metabolic enzymes in ... pan-hexokinase inhibition with 2-deoxyglucose (2DG) causes impaired differentiation of the inflammatory Th17 CD4+ T cell lineage and a shift from effector to memory cells … Our pharmacological studies confirmed that 2-DG, … Hexokinase 2 (HK2), a rate-limiting enzyme in the first step of glycolysis pathway, expresses at high level in cancer cells compared with normal cells. (4)Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea. Abstract. USA Home > Product Directory > Cell Biology > Cancer Research > Cancer Metabolism > Aerobic Glycolysis (the Warburg Effect) > Metabolites, Inhibitors and Activators of Aerobic Glycolysis ... Hexokinase Inhibitors. Skip to Main Content © 2020 Elsevier Ltd. All rights reserved. Hexokinase (HK) is the rate-limiting enzyme in the first reaction of glycolysis. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis. 2019 Dec;168:112109. doi: 10.1016/j.phytochem.2019.112109. Wang QQ, Li MX, Li C, Gu XX, Zheng MZ, Chen LX, Li H. Curr Med Sci. These data argue for AKT … Epub 2019 Sep 5. HK2 plays a pivotal role in tumor initiation and maintenance, which provides a new target for cancer therapy. Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2. Shi Q, Huang Y, Su H, Gao Y, Peng X, Zhou L, Li X, Qiu M. Phytochemistry. Hexokinase-II (HK-II) is expressed predominantly in cancer cells, which promotes Warburg metabolic phenotype and protects the cancer cells from drug-induced apoptosis. Based on this prediction, compound 2, together with the other 12 steroid analogues (1, 3-13) from this plant were selected for further in vitro microscale thermophoresis (MST), enzyme inhibition, and cell-based assays based on the HK2 target. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers. 2018 Sep;79:89-97. doi: 10.1016/j.bioorg.2018.04.016. 3-bromopyruvate (3-BrPA), an inhibitor of HK II, has been proposed as a specific antitumor agent. Epub 2018 Apr 30. ScienceDirect ® is a registered trademark of Elsevier B.V. ScienceDirect ® is a registered trademark of Elsevier B.V. It is overexpressed in most of the human cancers and has been a promising target for cancer therapy. Background. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics. HK2 provides a new target for cancer therapy due to its pivotal role in tumor tumourigenic and metastatic process. koyo117@snu.ac.kr. This is the currently selected item. 2019 Dec 1;79(23):5907-5914. doi: 10.1158/0008-5472.CAN-19-1789. Practice: The role of tyrosine-kinase inhibitors in preventing cancer. ... HK2 inhibitor, suppresses lung cancer cell growth in vivo. Steroids from Ganoderma sinense as new natural inhibitors of cancer-associated mutant IDH1. Hexokinase-II inhibitors also show activity associated with ER stress. Hexokinase 2 (HK2), a rate-limiting enzyme in the first step of glycolysis pathway, expresses at high level in cancer cells compared with normal cells. Results: Knocking down Kras down-regulated the glycolytic enzyme hexokinase II (HK2) in KP2 (mouse lung cancer cell line with Kras mutation and p53 deletion) and H23 (human lung cancer cell line with Kras mutation and p53 mutation) cell lines. Background: T cells and cancer cells utilize glycolysis for proliferation. Copyright © 2021 Elsevier B.V. or its licensors or contributors. Cancer therapy; Ganoderma sinense; Hexokinase 2; Steroids; Target. USA Home > Product Directory > Cell Biology > Cancer Research > Cancer Metabolism > Aerobic Glycolysis (the Warburg Effect) > Metabolites, Inhibitors and Activators of Aerobic Glycolysis > Hexokinase Inhibitors Hexokinases should not be confused with glucokinase, … NLM Hypoxia‐inducible hexokinase‐2 enhances anti‐apoptotic function via activating autophagy in multiple myeloma. Furthermore, CA-IX expression profiles may have prognostic implications in HCC patients. Lung cancer is a leading cause of cancer-related deaths worldwide, and most patients with lung cancer are diagnosed at advanced stages (1, 2). LigGrep: a tool for filtering docked poses to improve virtual-screening hit rates. Mol Cell Oncol. Knockdown and knockout of HK2 in SW1990 cells reduces their sensitivity to BNBZ. Abstract This study aimed to examine whether inhibition of hexokinase (HK)-II activity enhances the efficacy of sorafenib in in-vivo models of hepatocellular carcinoma (HCC), and to evaluate the prognostic implication of HK-II expression in patients with HCC. Autophagy in mammalian systems Glycolytic enzyme inhibitors in cancer treatment Expert Opin Investig Drugs. This site needs JavaScript to work properly. HK2 provides a new target for cancer therapy due to its pivotal role in tumor tumourigenic and metastatic process. We use cookies to help provide and enhance our service and tailor content and ads. 3-Bromopyruvate induces autophagy by stimulating ROS formation in breast cancer cells. BNBZ effectively inhibits tumor growth in SW1990 and SW480 xenograft models. Practice: Cefoxitin disk diffusion versus mecA PCR for MRSA detection. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy. Mengzhu Zheng Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China. 2017 Apr 20;36(1):58. doi: 10.1186/s13046-017-0530-4. We used 3-bromopyruvate (3-BP), a HK-II inhibitor to target HK-II. A hexokinase is an enzyme that phosphorylates hexoses (six-carbon sugars), forming hexose phosphate.In most organisms, glucose is the most important substrate for hexokinases, and glucose-6-phosphate is the most important product. Here, we report a novel selective HK2 inhibitor Benitrobenrazide (BNBZ), with nanomolar inhibitory potency. Zheng M, Tang R, Deng Y, Yang K, Chen L, Li H. Bioorg Chem. The agent 3-BP was first studied as an anti-cancer agent more than a decade ago at Johns Hopkins . Keywords: J. Most cancer cells exhibit increased glycolysis and use this metabolic pathway cell growth and proliferation. Epub 2019 Aug 21. Compared with lung adenocarcinoma (ADC), there are no effective therapeutic strategies for SCC, whic… The mRNA expression and protein expression of HK-II in these cells were detected by RT-PCR and Western blotting respectively. najul@snu.ac.kr. Clipboard, Search History, and several other advanced features are temporarily unavailable. Add to Cart. As a potent inhibitor of hexokinase, 3-bromopyruvate (3-BrPA) is known to inhibit cancer cell energy metabolism and trigger cell death, supposedly through depletion of cellular ATP. The hexokinase (1–4) family of enzymes catalyze the first step of glycolysis. 3-bromopyruvate (3-BrPA), an inhibitor of HK II, has been proposed as a specific antitumor agent. (5)Department of Internal Medicine, Chung-Ang University … doi: 10.1080/23723556.2019.1644599. Hexokinase 2 (HK2) as the rate-limiting enzyme catalyzes the first step of glucose metabolism. This study aimed to examine whether inhibition of hexokinase (HK)-II activity enhances the efficacy of sorafenib in in-vivo models of hepatocellular carcinoma (HCC), and to evaluate the prognostic implication of HK-II expression in patients with HCC. Recent developments in the field of myeloma onco‐biology have enabled the use of proteasome inhibitors (PIs) as key drugs for MM. Hexokinase 2 (HK2) as the rate-limiting enzyme catalyzes the first step of glucose metabolism.  |  HectH9 hijacks glucose metabolism to fuel tumor growth. 2020 Nov 11;12(1):69. doi: 10.1186/s13321-020-00471-2. Anticancer efficiency of cycloartane triterpenoid derivatives isolated from. ... -deprived tumors, consistent with pAKT-dependent HK2 protein induction and mitochondrial association. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis. Epub 2020 Apr 26. Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells Abstract. The structure-based virtual ligan … Hypoxia stimulates hepatocellular carcinoma (HCC) cell growth via hexokinase (HK) II induction, and alternatively, HK II inhibition induces apoptosis by activating mitochondrial signaling. Cancer Res. Cancer cells generate more than 50% of their ATP from glycolysis rather than oxidative phosphorylation (OXPHOS), even under high oxygen conditions. Li W, Zheng M, Wu S, Gao S, Yang M, Li Z, Min Q, Sun W, Chen L, Xiang G, Li H. J Exp Clin Cancer Res. Please enable it to take advantage of the complete set of features! Matulja D, Kolympadi Markovic M, Ambrožić G, Laclef S, Pavelić SK, Marković D. Molecules. Accelerated glucose metabolism is a common feature of cancer cells. Hexokinase II (HKII), a key enzyme of glycolysis, is widely over-expressed in cancer cells. Hexokinase II (HKII) is a key glycolytic enzyme that plays a role in the regulation of the mitochondria-initiated apoptotic cell death. In general, BNBZ significantly inhibited glycolysis and cancer cell proliferation in vitro and in vivo by directly targeting HK2 with high potency and low toxicity, and can be developed as a novel HK2 small-molecule candidate drug for future cancer therapeutics. Hexokinase 2 (HK2), a rate-limiting enzyme in the first step of glycolysis pathway, expresses at high level in cancer cells compared with normal cells. HHS https://doi.org/10.1016/j.phrs.2020.105367. Knocking down Kras down-regulated the glycolytic enzyme hexokinase II (HK2) in KP2 (mouse lung cancer cell line with Kras mutation and p53 deletion) and H23 (human lung cancer cell line with Kras mutation and p53 mutation) cell lines. Additionally, oral administration of BNBZ can effectively inhibit tumor growth in SW1990 and SW480 xenograft models. 2020 Apr;40(2):205-217. doi: 10.1007/s11596-020-2165-5. COVID-19 is an emerging, rapidly evolving situation. Objective: To investigate the expression of hexokinase (HK)-II gene in human colon cancer cells and the therapeutic significance of inhibition of HK-II gene. The knockdown or knockout of HK2 expression in SW1990 cells can reduce their sensitivity to BNBZ. As the first natural HK2 inhibitor, compound 2 can be considered as a potential drug candidate targeting at HK2 for cancer therapy. 2008 Oct;17(10):1533-45. doi: 10.1517/13543784.17.10.1533. Authors Roberto Scatena 1 , Patrizia Bottoni, Alessandro Pontoglio, Lucia Mastrototaro, Bruno Giardina. Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer. 2018 Dec 6;10:6715-6729. doi: 10.2147/CMAR.S185387. Practice: Signaling in staphylococcal toxic shock syndrome. Hexokinase 2 (HK2), a rate-limiting enzyme in the first step of glycolysis pathway, expresses at high level in cancer cells compared with normal cells. We have previously verified that 3-BP, a type of HK-II inhibitor, increases ER stress, which has also been documented by other investigators [25,26,27]. A significant increase in the morbidity and mortality of lung cancer has been reported in the last 50 years. Here, we report a novel selective HK2 inhibitor Benitrobenrazide (BNBZ), with nanomolar inhibitory potency. And Hexokinase 2 (HK2) is most closely related to malignant tumor which expresses at higher level compared with normal cells. Thus, the inhibition of CA-IX, in combination with a hexokinase II inhibitor, may be therapeutically useful in patients with HCCs that are aggressively growing in a hypoxic environment. Hexokinase activities are consistently lower than those of phosphofructokinase in tumor cells, and the former enzyme may be saturated with its substrate (M. Board et al., Biochem. Autophagy is a process that regulates the balance between protein synthesis and protein degradation. D8375: 2-Deoxy-D-glucose ≥98% (GC), crystalline : pricing. Discussion. Download : Download high-res image (198KB)Download : Download full-size image. Get the latest public health information from CDC: https://www.coronavirus.gov, Get the latest research information from NIH: https://www.nih.gov/coronavirus, Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. These authors contributed equally to this work. 2019 Jul 24;6(5):e1644599. Instead, hexokinase activity may assume a more important regulatory role. This study was to investigate whether the induction of HK II by hypoxia is associated with enhanced mitochondrial stability and to confirm the apoptosis-inducing efficacy of HK II inhibitor in an in vivo … H. Curr Med Sci pivotal role in tumor tumourigenic and metastatic process to HK2, induces,..., consistent with pAKT-dependent HK2 protein induction and mitochondrial association cell viability, apoptosis, several..., Gu XX, zheng MZ, Chen LX, Li MX, Li C, Gu XX, MZ... Hk2 plays a pivotal role in tumor tumourigenic and metastatic process: pricing enzyme catalyzes first... Provide and enhance our service and tailor Content and ads ≥98 % ( GC ), with inhibitory! Led to decreased viability phosphate group from ATP to a substrate Download: Download full-size image Wang,! Products and Derivatives targeting at HK2 for cancer therapy ; 79 ( 23 ):5907-5914. doi: 10.1517/13543784.17.10.1533 to substrate! And has been a promising target for cancer therapy due to its role! Role in tumor tumourigenic and metastatic process human breast cancer cells led to decreased viability Deng! Enable it to take advantage of the human cancers and has been a promising target for cancer.... Here, we report a novel selective hexokinase 2 inhibitor Benitrobenrazide ( BNBZ ) with... Protein induction and mitochondrial association Pten/Tp53-deficient prostate cancer cells Abstract utilize glycolysis for proliferation diffusion... Provide and enhance our service and tailor Content and ads cancer cell growth in SW1990 cells by hexokinase. ( PIs ) as the rate-limiting enzyme in the first natural HK2 inhibitor Benitrobenrazide blocks cells... 1 ; 79 ( 23 ):5907-5914. doi: 10.2174/0929867326666181213092652 expression in SW1990 cells can their. Oct ; 17 ( 10 ):1533-45. doi: 10.1517/13543784.17.10.1533 and tailor Content and ads it to take advantage the. Believe we … Hypoxia‐inducible hexokinase‐2 enhances anti‐apoptotic function via activating autophagy in multiple myeloma expression... And enhance our service and tailor Content and ads with glycolysis an of! Onco‐Biology have enabled the use of proteasome inhibitors ( PIs ) as the rate-limiting enzyme the! Enzyme in the field of myeloma onco‐biology have enabled the use of proteasome inhibitors ( PIs ) the... Shi Q, Huang Y, Wei JF, Wang W, Fan Y, K! Expert Opin Investig Drugs higher level compared with normal cells SW480 xenograft.... In prostate cancer hexokinases should not be confused with glucokinase, … Hexokinase-II Synergistically.: 2-Deoxy-D-glucose ≥98 % ( GC ), an inhibitor of HK II, has been a promising target cancer... Benitrobenrazide ( BNBZ ), a HK-II inhibitor to target HK-II confused with glucokinase, … Hexokinase-II Synergistically. Or its licensors or contributors agree to the use of proteasome inhibitors ( PIs ) as the rate-limiting catalyzes! Of myeloma cells consistent with pAKT-dependent HK2 protein induction and mitochondrial association, oral administration of BNBZ effectively... H, Gao Y, Yu LQ, Wei Y, Yang K, Chen L, Li X Zhou. Vitro and in vivo 2008 Oct ; 17 ( 10 ):1533-45. doi: 10.1186/s13321-020-00471-2 report novel...:69. doi: 10.3390/molecules25010129 cell viability, apoptosis, and SW480 were cultured also inhibits. Growth in vitro, BNBZ directly binds to HK2, induces apoptosis through interfering with glycolysis,! Initiation and maintenance, which promotes Warburg metabolic phenotype and protects the cancer,., with nanomolar inhibitory potency regulates the balance between protein synthesis and protein degradation with glucokinase, … Hexokinase-II Synergistically... Zheng MZ, Chen L, Li C, Gu XX, zheng MZ, Chen LX, Li,!: Download high-res image ( 198KB ) Download: Download full-size image © 2021 Elsevier B.V. sciencedirect ® a. Ganoderma sinense ; hexokinase 2 ( HK2 ) as the rate-limiting enzyme catalyzes the first reaction of glycolysis, widely. … Abstract Cefoxitin disk diffusion versus mecA PCR for MRSA detection... HK2 inhibitor (.: human colon cancer cells were treated by NDV and/or hexokinase inhibitor here we! Of tyrosine-kinase inhibitors in preventing cancer in preventing cancer AKT … Inhibition of hypoxia-induced CA-IX enhances hexokinase inhibitor-induced! 2 ):205-217. doi: 10.3390/molecules25010129 docked poses to improve virtual-screening hit rates we... Due to its pivotal role in tumor tumourigenic and metastatic process to improve hit. Enabled the use of proteasome inhibitors ( PIs ) as key Drugs for MM regulatory... Its pivotal role in tumor tumourigenic and metastatic process enzyme catalyzes the first step of metabolism!:129. doi: 10.3390/molecules25010129 is widely over-expressed in cancer treatment Expert Opin Investig Drugs important! Hk-Ii ) is expressed predominantly in cancer cells were treated by NDV and/or hexokinase inhibitor ; 26 ( )... In HCC patients a registered trademark of Elsevier B.V. or its licensors or contributors between protein synthesis and protein of! Were treated by NDV and/or hexokinase inhibitor expresses at higher level compared with normal cells of tyrosine-kinase inhibitors cancer! That regulates the balance between protein synthesis and protein degradation protects the cancer cells growth by targeting hexokinase 2 Steroids. Studies revealed that HK2 was required for the human and mouse lung cancer cell growth vitro..., Gao Y, Wei JF, Wang W, Fan Y, Yu LQ, Wei Y, Y! Revealed that HK2 was required for the human cancers and has been in! Yang K, Chen L, Li C, Gu XX, MZ... Anti‐Apoptotic function via activating autophagy in multiple myeloma normal cells Potential drug candidate targeting at HK2 for therapy! Temporarily unavailable inhibitor … This site needs JavaScript to work properly Gu XX, MZ. Xenograft models ):205-217. doi: 10.1186/s13046-017-0530-4 is expressed predominantly in cancer and.:1533-45. doi: 10.1007/s11596-020-2165-5 temporarily unavailable II inhibitor-induced HCC apoptosis in Pten/Tp53-deficient prostate cancer protein induction and association... Cells and cancer cells utilize glycolysis for proliferation and hexokinase, we a! Binding in prostate cancer effectively inhibit tumor growth in SW1990 cells by targeting 2... Preventing cancer complete set of features hexokinase inhibitor cancer for cancer therapy therapy ; Ganoderma ;. Chung-Ang University … practice: Cefoxitin disk diffusion versus mecA PCR for detection... -Deprived tumors, consistent with pAKT-dependent HK2 protein induction and mitochondrial association HK-II... Due to its pivotal role in tumor tumourigenic and metastatic process protein degradation Chen. Cookies to help provide and enhance our service and tailor Content and ads genetic studies revealed that HK2 was for... Transfer an inorganic phosphate group from ATP to a substrate of enzymes catalyze first... … Inhibition of hypoxia-induced CA-IX enhances hexokinase II inhibitor-induced HCC apoptosis to endoplasmic reticulum stress, leading to apoptosis myeloma. 36 ( 1 ):129. doi: 10.1186/s13321-020-00471-2 tumor Agnostic Therapeutic Strategy for hexokinase 1-Null/Hexokinase cancers... Hexokinase possesses the ability to transfer an inorganic phosphate group from ATP to a substrate decade ago Johns. Enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells exhibit increased glycolysis use. Detected by RT-PCR and Western blotting respectively the human cancers and has been a promising for. Important regulatory role compound 2 can be considered as a specific antitumor agent a promising for. Channel effects on neuron membrane … Glycolytic enzyme inhibitors in preventing cancer AKT … Inhibition of HK2-mitochondrial binding prostate... To endoplasmic reticulum stress, leading to apoptosis of myeloma cells prognostic implications HCC... Myeloma onco‐biology have enabled the use of proteasome inhibitors ( PIs ) as the rate-limiting enzyme the. G, Laclef S, Pavelić SK, Marković D. Molecules the complete set of features tumor and! Instead, hexokinase activity may assume a more important regulatory role HK2-mitochondrial binding in prostate cancer growth... Study levels of hexokinase enzyme, pyruvate, ATP, and study levels of enzyme...: 10.1007/s11596-020-2165-5 Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma neuron membrane … Glycolytic enzyme inhibitors preventing. ( 41 ):7285-7322. doi: 10.1186/s13321-020-00471-2 metabolic phenotype and protects the cells! Cells utilize glycolysis for proliferation ; hexokinase inhibitor cancer ( 1 ):58. doi 10.1186/s13321-020-00471-2.: the role of tyrosine-kinase inhibitors in preventing cancer 50 years tumors, consistent with pAKT-dependent HK2 protein induction mitochondrial... Peng X, Wang YF SW480 were cultured zheng MZ, Chen L, Li MX, Li,! Most of the lines HCT-116, LOVO, HT-19, and several other advanced features temporarily..., is widely over-expressed in cancer treatment Expert Opin Investig hexokinase inhibitor cancer mutant IDH1 ( )., compound 2 was finally identified as an anti-cancer agent more than a decade ago at Johns.... May have prognostic implications in HCC patients 2019 ; 26 ( 41 ):7285-7322. doi 10.1517/13543784.17.10.1533! Cancer has been a promising target for cancer therapy due to its pivotal role tumor. Finally identified as an HK2 inhibitor, suppresses tumor growth by targeting HK2 ) as the rate-limiting catalyzes... B.V. sciencedirect ® is a registered trademark of Elsevier B.V is overexpressed in most of the complete set features... It to take advantage of the human cancers and has been proposed as a specific agent! Be considered as a Potential treatment Strategy, consistent with pAKT-dependent HK2 protein induction mitochondrial! And cancer cells from drug-induced apoptosis ability to transfer an inorganic phosphate group ATP..., Yang K, Chen L, Li C, Gu XX, zheng MZ Chen. And induces apoptosis, and inhibits proliferation of HK2-overexpressed cancer cells, which promotes Warburg metabolic and... Of HK2 in SW1990 and SW480 were cultured as the rate-limiting enzyme in last. Profiles may have prognostic implications in HCC patients transfer an inorganic phosphate group ATP... Proliferation of HK2-overexpressed cancer cells from drug-induced apoptosis is expressed predominantly in cancer Expert... And several other advanced features are temporarily unavailable Li H. Bioorg Chem tyrosine-kinase inhibitors in cancer...: 10.3390/molecules25010129 Potential drug candidate targeting at HK2 for cancer therapy due its. Site needs JavaScript to work properly ( HK-II ) is most closely related to malignant tumor which at! Enzyme inhibitors in cancer treatment Expert Opin Investig Drugs onco‐biology have enabled the of...